What does APOTHEEK RUYSSCHAERT do?

APOTHEEK RUYSSCHAERT is a pharmacy in Mol. Public Limited, started on 27 December 1989, 1 establishment.

What is the address of APOTHEEK RUYSSCHAERT?

The registered office of APOTHEEK RUYSSCHAERT is located at Turnhoutsebaan 201, 2400 Mol.

Is APOTHEEK RUYSSCHAERT still active?

Yes. According to the CBE (30 October 2026) APOTHEEK RUYSSCHAERT is active, legal situation “Normale toestand”, started on 27 December 1989.

Is APOTHEEK RUYSSCHAERT registered on Peppol?

Yes, APOTHEEK RUYSSCHAERT is registered on the Peppol network with ID 0208:0439317354.

What is the enterprise number of APOTHEEK RUYSSCHAERT?

The enterprise number of APOTHEEK RUYSSCHAERT is BE0439317354.

When was APOTHEEK RUYSSCHAERT founded?

APOTHEEK RUYSSCHAERT was founded on 27 December 1989.

Who are the directors of APOTHEEK RUYSSCHAERT?

According to the 2025 annual accounts, the directors of APOTHEEK RUYSSCHAERT are: Katlijne Ruysschaert, K & K MANAGEMENT BV.

Is APOTHEEK RUYSSCHAERT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 December 1989; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK RUYSSCHAERT make in 2025?

APOTHEEK RUYSSCHAERT posted a profit after taxes of € 435,735 in financial year 2025.

What is the revenue of APOTHEEK RUYSSCHAERT?

As a small company, APOTHEEK RUYSSCHAERT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 628,378.

How much does an employee at APOTHEEK RUYSSCHAERT earn?

The average wage cost per full-time employee at APOTHEEK RUYSSCHAERT was € 62,300 in 2023: staff costs of € 81,003 for 1.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK RUYSSCHAERT have?

According to the 2025 annual accounts, APOTHEEK RUYSSCHAERT has 0.8 full-time equivalents (FTE).

APOTHEEK RUYSSCHAERT (Public Limited) - Mol

Dossier APOTHEEK RUYSSCHAERT, printed on 30 October 2026 from databakkes.be/en/0439317354/apotheek-ruysschaert. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 59 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK RUYSSCHAERT from Mol, company number BE0439317354, closed financial year 2025 with a result of € 435,735 after tax. For that financial year APOTHEEK RUYSSCHAERT recorded a gross margin of € 628,378 and equity of € 120,334. Compared with financial year 2024, the result moved from € 405,105 to € 435,735. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.

What it is worth Growing

€ 120,334

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 435,735

▲ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 352,866

▼ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 428,000 paid out

98 % of the profit went to the shareholders, mostly to K & K MANAGEMENT (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

0.8

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 68,394

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 32,204

▼ 18% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 64,386

▼ 37% vs 2024

€ 17,849 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 105,486

▼ 38% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 9,234

▲ 4% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 455,572 Gross margin 2022: € 455,572 First fiscal year in the series	€ 544,001 Gross margin 2023: € 544,001 ▲ 19% vs 2022 (€ 455,572) Favourable step	€ 593,338 Gross margin 2024: € 593,338 ▲ 9% vs 2023 (€ 544,001) Favourable step	€ 628,378 Gross margin 2025: € 628,378 ▲ 6% vs 2024 (€ 593,338) Favourable step	▲ 6%
Profit after taxes	€ 361,302 Profit after taxes 2022: € 361,302 First fiscal year in the series	€ 418,162 Profit after taxes 2023: € 418,162 ▲ 16% vs 2022 (€ 361,302) Favourable step	€ 405,105 Profit after taxes 2024: € 405,105 ▼ 3% vs 2023 (€ 418,162) Unfavourable step	€ 435,735 Profit after taxes 2025: € 435,735 ▲ 8% vs 2024 (€ 405,105) Favourable step	▲ 8%
Equity	€ 119,831 Equity 2022: € 119,831 First fiscal year in the series	€ 119,993 Equity 2023: € 119,993 Unchanged (€ 119,831) Favourable step	€ 120,098 Equity 2024: € 120,098 Unchanged (€ 119,993) Favourable step	€ 120,334 Equity 2025: € 120,334 Unchanged (€ 120,098) Favourable step
Total debts	€ 1,033,582 Total debts 2022: € 1,033,582 First fiscal year in the series	€ 1,330,962 Total debts 2023: € 1,330,962 ▲ 29% vs 2022 (€ 1,033,582) Unfavourable step	€ 1,249,844 Total debts 2024: € 1,249,844 ▼ 6% vs 2023 (€ 1,330,962) Favourable step	€ 1,050,998 Total debts 2025: € 1,050,998 ▼ 16% vs 2024 (€ 1,249,844) Favourable step	▼ 16%
Cash	€ 448,975 Cash 2022: € 448,975 First fiscal year in the series	€ 421,333 Cash 2023: € 421,333 ▼ 6% vs 2022 (€ 448,975) Unfavourable step	€ 512,943 Cash 2024: € 512,943 ▲ 22% vs 2023 (€ 421,333) Favourable step	€ 352,866 Cash 2025: € 352,866 ▼ 31% vs 2024 (€ 512,943) Unfavourable step	▼ 31%
Land & buildings	€ 197,004 Land & buildings 2022: € 197,004 First fiscal year in the series	€ 180,500 Land & buildings 2023: € 180,500 ▼ 8% vs 2022 (€ 197,004) Unchanged	€ 165,943 Land & buildings 2024: € 165,943 ▼ 8% vs 2023 (€ 180,500) Unchanged	€ 151,385 Land & buildings 2025: € 151,385 ▼ 9% vs 2024 (€ 165,943) Unchanged	▼ 9%
Retained profit	€ 57,831 Retained profit 2022: € 57,831 First fiscal year in the series	€ 57,993 Retained profit 2023: € 57,993 Unchanged (€ 57,831) Favourable step	€ 58,098 Retained profit 2024: € 58,098 Unchanged (€ 57,993) Favourable step	€ 58,334 Retained profit 2025: € 58,334 Unchanged (€ 58,098) Favourable step
Dividend	€ 361,000 Dividend 2022: € 361,000 First fiscal year in the series	€ 418,000 Dividend 2023: € 418,000 ▲ 16% vs 2022 (€ 361,000) Unchanged	€ 397,500 Dividend 2024: € 397,500 ▼ 5% vs 2023 (€ 418,000) Unchanged	€ 428,000 Dividend 2025: € 428,000 ▲ 8% vs 2024 (€ 397,500) Unchanged	▲ 8%
Bank debt	€ 218,783 Bank debt 2022: € 218,783 First fiscal year in the series	€ 161,179 Bank debt 2023: € 161,179 ▼ 26% vs 2022 (€ 218,783) Favourable step	€ 102,759 Bank debt 2024: € 102,759 ▼ 36% vs 2023 (€ 161,179) Favourable step	€ 64,386 Bank debt 2025: € 64,386 ▼ 37% vs 2024 (€ 102,759) Favourable step	▼ 37%
Balance sheet total	€ 1,153,413 Balance sheet total 2022: € 1,153,413 First fiscal year in the series	€ 1,450,956 Balance sheet total 2023: € 1,450,956 ▲ 26% vs 2022 (€ 1,153,413) Unchanged	€ 1,369,942 Balance sheet total 2024: € 1,369,942 ▼ 6% vs 2023 (€ 1,450,956) Unchanged	€ 1,171,332 Balance sheet total 2025: € 1,171,332 ▼ 14% vs 2024 (€ 1,369,942) Unchanged	▼ 14%
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1.3 Employees (FTE) 2023: 1.3 ▲ 0.3 vs 2022 (1) Unchanged	0.8 Employees (FTE) 2024: 0.8 ▼ 0.5 vs 2023 (1.3) Unchanged	0.8 Employees (FTE) 2025: 0.8 Unchanged (0.8) Unchanged

Key figures of APOTHEEK RUYSSCHAERT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK RUYSSCHAERT?

What happened at APOTHEEK RUYSSCHAERT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Katlijne Ruysschaert stepped down as director. NBB
2029 K & K MANAGEMENT BV stepped down as director. NBB
Jul 16, 2026 New annual accounts for financial year 2025: profit of € 435,735 (▲ 8% vs 2024). Source: NBB ↗
Jan 18, 1990 New establishment in Mol. KBO
Dec 27, 1989 Start of the company according to the CBE. KBO

In short

From € 361,302 profit in 2022 to € 435,735 profit in 2025.

Paid € 167,934 in corporate taxes since 2022.

Best year ever: 2025, with € 435,735 profit.

On average € 418,500 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

K & K MANAGEMENT 99.9%

The stake of K & K MANAGEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK RUYSSCHAERT

The shares are held by K & K MANAGEMENT (99.9%).

Directors

According to the 2025 annual accounts

Katlijne Ruysschaert

Director

Also active at: K & K MANAGEMENT

· until 2029

K & K MANAGEMENT BV

Director · represented by Smet Koen

Also active at: Apotheek Ruysschaert K.

· until 2029

Shareholders

K & K MANAGEMENT

99.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Turnhoutsebaan 201

2400 Mol

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0439.317.354

VAT number

BE 0439.317.354

Registered office

Turnhoutsebaan 201, 2400 Mol

Names & denominations

APOTHEEK RUYSSCHAERT

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

27 December 1989

Peppol

Active · Active since 26 Jun 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK RUYSSCHAERT

Warning lights

Financials

What happened to APOTHEEK RUYSSCHAERT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions